Search Results

There are 41112 results for: content related to: EXAMINING THE LINK BETWEEN CASH FLOW, MARKET VALUE, AND RESEARCH AND DEVELOPMENT INVESTMENT SPENDING IN THE MEDICAL DEVICE INDUSTRY

  1. Relative CEO Underpayment and CEO Behaviour Towards R&D Spending

    Journal of Management Studies

    Volume 47, Issue 6, September 2010, Pages: 1095–1122, Eric A. Fong

    Version of Record online : 22 JUN 2009, DOI: 10.1111/j.1467-6486.2009.00861.x

  2. An Integrated Agency–Resource Dependence View of the Influence of Directors' Human and Relational Capital on Firms' R&D Spending

    Journal of Management Studies

    Volume 48, Issue 6, September 2011, Pages: 1217–1242, Thomas Dalziel, Richard J. Gentry and Michael Bowerman

    Version of Record online : 5 APR 2011, DOI: 10.1111/j.1467-6486.2010.01003.x

  3. Machines that Go ‘Ping’: Medical Technology and Health Expenditures in OECD Countries

    Health Economics

    Volume 24, Issue 8, August 2015, Pages: 1027–1041, Peter Willemé and Michel Dumont

    Version of Record online : 28 JUL 2014, DOI: 10.1002/hec.3089

  4. Cost Signals under Uncertain R&D Outcomes

    Australian Economic Papers

    Volume 53, Issue 3-4, December 2014, Pages: 207–229, Chris Y. Tung and Chun-Chieh Wang

    Version of Record online : 27 MAR 2015, DOI: 10.1111/1467-8454.12029

  5. Income and Technology as Drivers of Australian Healthcare Expenditures

    Health Economics

    Volume 26, Issue 7, July 2017, Pages: 853–862, Xiaohui You and Albert A. Okunade

    Version of Record online : 29 SEP 2016, DOI: 10.1002/hec.3403

  6. You have full text access to this OnlineOpen article
    Family Influence and R&D Spending in Dutch Manufacturing SMEs: The Role of Identity and Socioemotional Decision Considerations

    Journal of Product Innovation Management

    Jasper Brinkerink and Yannick Bammens

    Version of Record online : 24 OCT 2017, DOI: 10.1111/jpim.12428

  7. THE EFFECT OF NATIONAL HEALTH INSURANCE ON MORTALITY AND THE SES–HEALTH GRADIENT: EVIDENCE FROM THE ELDERLY IN TAIWAN

    Health Economics

    Volume 22, Issue 1, January 2013, Pages: 52–72, Shao-Hsun Keng and Sheng-Jang Sheu

    Version of Record online : 3 JAN 2012, DOI: 10.1002/hec.1815

  8. A Longitudinal Study of the Impact of R&D, Patents, and Product Innovation on Firm Performance

    Journal of Product Innovation Management

    Volume 27, Issue 5, September 2010, Pages: 725–740, Kendall W. Artz, Patricia M. Norman, Donald E. Hatfield and Laura B. Cardinal

    Version of Record online : 7 JUL 2010, DOI: 10.1111/j.1540-5885.2010.00747.x

  9. Knowing when to leap: Transitioning between exploitative and explorative R&D

    Strategic Management Journal

    Volume 35, Issue 1, January 2014, Pages: 126–145, Ram Mudambi and Tim Swift

    Version of Record online : 7 MAY 2013, DOI: 10.1002/smj.2097

  10. Endogenous Technology Adoption and Medical Costs

    Health Economics

    Volume 25, Issue 9, September 2016, Pages: 1123–1147, Karine Lamiraud and Stephane Lhuillery

    Version of Record online : 4 AUG 2016, DOI: 10.1002/hec.3361

  11. The Inverted U-Shaped Relationship between Corporate Philanthropy and Spending on Research and Development: A Case of Complementarity and Competition Moderated by Firm Size and Visibility

    Corporate Social Responsibility and Environmental Management

    Volume 24, Issue 6, November/December 2017, Pages: 465–477, Yongqiang Gao, Jian Wu and Taïeb Hafsi

    Version of Record online : 6 MAR 2017, DOI: 10.1002/csr.1420

  12. The impact of provider consolidation on physician prices

    Health Economics

    Caroline S. Carlin, Roger Feldman and Bryan Dowd

    Version of Record online : 4 MAY 2017, DOI: 10.1002/hec.3502

  13. You have full text access to this OnlineOpen article
    Adoption Decisions for Medical Devices in the Field of Cardiology: Results from a European Survey

    Health Economics

    Volume 26, Issue S1, February 2017, Pages: 124–144, Maximilian H. M. Hatz, Jonas Schreyögg, Aleksandra Torbica, Giuseppe Boriani and Carl R. B. Blankart

    Version of Record online : 31 JAN 2017, DOI: 10.1002/hec.3472

  14. Corporate Governance, Product Market Competition, and the Wealth Effect of R&D Spending Changes

    Financial Management

    Volume 46, Issue 3, Fall 2017, Pages: 717–742, Tsai-Ling Liao and Wen-Chun Lin

    Version of Record online : 4 DEC 2016, DOI: 10.1111/fima.12161

  15. Japanese Research Consortia: A Microeconometric Analysis of Industrial Policy

    The Journal of Industrial Economics

    Volume 46, Issue 2, June 1998, Pages: 207–233, Lee Branstetter and Mariko Sakakibara

    Version of Record online : 27 MAR 2003, DOI: 10.1111/1467-6451.00069

  16. CAN PRICE GET THE MONKEY OFF OUR BACK? A META-ANALYSIS OF ILLICIT DRUG DEMAND

    Health Economics

    Volume 23, Issue 1, January 2014, Pages: 55–68, Craig A. Gallet

    Version of Record online : 10 JAN 2013, DOI: 10.1002/hec.2902

  17. You have free access to this content
    The Effect of Medical Marijuana Laws on Body Weight

    Health Economics

    Volume 26, Issue 1, January 2017, Pages: 6–34, Joseph J. Sabia, Jeffrey Swigert and Timothy Young

    Version of Record online : 25 NOV 2015, DOI: 10.1002/hec.3267

  18. You have free access to this content
    HOW WELL DO DIAGNOSIS-RELATED GROUP SYSTEMS GROUP BREAST CANCER SURGERY PATIENTS?—EVIDENCE FROM 10 EUROPEAN COUNTRIES

    Health Economics

    Volume 21, Issue S2, August 2012, Pages: 41–54, David Scheller-Kreinsen and on behalf of the EuroDRG group

    Version of Record online : 19 JUL 2012, DOI: 10.1002/hec.2832

  19. THE CYCLICAL BEHAVIOUR OF PUBLIC AND PRIVATE HEALTH EXPENDITURE IN CHINA

    Health Economics

    Volume 22, Issue 9, September 2013, Pages: 1071–1092, Gang Chen, Brett Inder, Paula Lorgelly and Bruce Hollingsworth

    Version of Record online : 8 JUL 2013, DOI: 10.1002/hec.2957

  20. Heterogeneity in Smokers' Responses to Tobacco Control Policies

    Health Economics

    Volume 26, Issue 2, February 2017, Pages: 206–225, Erik Nesson

    Version of Record online : 1 DEC 2015, DOI: 10.1002/hec.3289